MedTrace Logo

Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)

NCT04017754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 452

Last updated 2021-07-30

Study results available
· View outcomes & findings →

Summary

The present study is based on the hypothesis, that recurrent pregnancy loss (RPL) is associated with abnormal plasma mannose binding lectin (p-MBL) level. Secondarily, p-MBL level may affect the reproductive and the perinatal outcome in the first pregnancy following RPL. Thus, the present study aim to examine whether MBL should be a biomarker for women at risk for RPL and, secondarily, affect the reproductive and perinatal outcome, and thereby help clinicians identify fragile women who need intensified perinatal care.

Conditions

  • Recurrent Miscarriage
  • Spontaneous Abortion
  • Mannose-Binding Lectin Deficiency
  • Habitual Abortion
  • Pregnancy Complications
  • Pregnancy Loss
  • Recurrent Pregnancy Loss

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Caroline Nørgaard-Pedersen · Aalborg University Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-03-29
Completion
2021-03-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04017754 on ClinicalTrials.gov